Ameriprise’s Foundation Medicine, Inc. FMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-10,855
Closed -$1.48M 3841
2018
Q2
$1.48M Buy
10,855
+7,069
+187% +$642K ﹤0.01% 2857
2018
Q1
$298K Buy
+3,786
New +$279K ﹤0.01% 3371
2014
Q3
Sell
-31,980
Closed -$863K 5962
2014
Q2
$863K Sell
31,980
-825
-3% -$20.9K ﹤0.01% 2825
2014
Q1
$1.06M Buy
32,805
+24,205
+281% +$787K ﹤0.01% 2703
2013
Q4
$205K Sell
8,600
-90,517
-91% -$2.53M ﹤0.01% 3134
2013
Q3
$3.93M Buy
+99,117
New +$3.65M ﹤0.01% 2088

Ameriprise's FMI Position: Q3 2018 in Review

Ameriprise sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 10,855 shares — an estimated $1.48M sold.

Ameriprise first reported a position in FMI in Q3 2013 and held it in 6 quarters. The position peaked at $3.93M in Q3 2013. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

  • Ameriprise reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
  • Ameriprise sold 10,855 Foundation Medicine, Inc. shares in Q3 2018, an estimated $1.48M.
  • Ameriprise first reported a position in Foundation Medicine, Inc. in Q3 2013 and held it in 6 quarters.
  • Ameriprise's Foundation Medicine, Inc. position peaked at $3.93M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.

Based on Ameriprise's 13F filing for Q3 2018, filed 14 Nov 2018.